Is Synbiotics Corp (SBIO) Going to Burn These Institutional Investors?

June 27, 2018 - By Henry Gaston

Sentiment for Synbiotics Corp (SBIO)

Synbiotics Corp (SBIO) institutional sentiment increased to 3 in Q1 2018. Its up 0.17, from 2.83 in 2017Q4. The ratio has improved, as 18 active investment managers increased and started new positions, while 6 cut down and sold positions in Synbiotics Corp. The active investment managers in our partner’s database now possess: 1.04 million shares, up from 529,771 shares in 2017Q4. Also, the number of active investment managers holding Synbiotics Corp in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 3 Reduced: 3 Increased: 13 New Position: 5.

The ETF increased 0.05% or $0.02 during the last trading session, reaching $37.88. About 53,818 shares traded or 21.66% up from the average. ALPS Medical Breakthroughs ETF (SBIO) has risen 47.45% since June 27, 2017 and is uptrending. It has outperformed by 34.88% the S&P500.

Barometer Capital Management Inc. holds 0.59% of its portfolio in ALPS Medical Breakthroughs ETF for 204,400 shares. Ntv Asset Management Llc owns 51,850 shares or 0.5% of their US portfolio. Moreover, Virtu Financial Llc has 0.08% invested in the company for 42,260 shares. The New York-based Bouchey Financial Group Ltd has invested 0.06% in the stock. Cambridge Trust Co, a Massachusetts-based fund reported 22,114 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.